Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season
THURSDAY, March 10, 2022 (HealthDay News) -- During the 2021-2022 season, influenza vaccination did not reduce the risk for outpatient medically attended illness with influenza A(H3N2) viruses that have predominated this season, according to research published in the March 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Noting that most influenza viruses detected this season have been A(H3N2), Jessie R. Chung, M.P.H., from the CDC in Atlanta, and colleagues produced an interim report using data from 3,636 children and adults with acute respiratory infection during Oct. 4, 2021, to Feb. 12, 2022.
The researchers found that vaccine effectiveness against medically attended outpatient acute respiratory infection associated with influenza A(H3N2) virus was 16 percent overall, which was not statistically significant.
"Physicians should not wait for confirmatory influenza laboratory testing, and the decision to use antiviral medication should not be influenced by patient influenza vaccination status," the authors write. "Clinicians should be aware that influenza activity might continue or increase, and influenza should be considered as a possible diagnosis in all patients with acute respiratory infection."
Several authors disclosed financial ties to the pharmaceutical industry.
Related Posts
The #1 Enemy of Good Sleep for School Kids: Screens
SATURDAY, Aug. 19, 2023 (HealthDay News) -- Video games and social media are...
Los adultos con autismo y enfermedades mentales podrían tener un riesgo más alto de una COVID grave
MIÉRCOLES, 8 de septiembre de 2021 (HealthDay News) -- Los adultos con autismo,...
Medical Debt Can Crush Even the Insured, Study Shows
MONDAY, Sept. 19, 2022 (HealthDay News) -- Weeks after a stay in the hospital,...
2005 to 2019 Saw Decline in Cervical Cancer Screening Rates
WEDNESDAY, Feb. 2, 2022 (HealthDay News) -- Guideline-concordant cervical cancer...